CT-301/R

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCT-301/R
Drug Alias NameHMGB1 restenosis therapy (Bio3/Creabilis)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHigh Mobility Group Protein B1 modulators
TargetsHigh Mobility Group Protein B1
Therapy Area/IndicationsCoronary Restenosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCreabilis Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBio3 ResearchCreabilis Sa
Active IndicationsN/A
Inactive IndicationsCoronary Restenosis

Other Information

ATC CodeN/A
Related LinksN/A